Roche and Exelixis roll toward FDA approval with a melanoma cocktail

Damian Garde

and are one step closer to FDA for their skin cancer-treating combination treatment, as the agency has accepted their application and promised a speedy review.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS